Rare Disease Report: Is Eteplirsen Effective in Non-ambulatory Duchenne Patients?

February 1, 2016

Christine McSherry, founder of the Jett Foundation talks about her son’s experience as a non-ambulatory Duchenne muscular dystrophy patient taking Sarepta’s eteplirsen.

SOURCE | RARE DISEASE REPORT

Diagnosis

2023 RARE Mental Health Grant Recipients Announced

Global Genes is pleased to announce the Rare Disease Patient Advocacy Organizations receiving 2023 RARE Mental Health […]

podcast

Seeking a Sustainable Business Developing on N-of-1 Therapies

The ability to pinpoint the underlying genetic causes of diseases and rapidly generate genetic medicines to address […]

Diagnosis

Global Genes Team Shares Their Stories on World Rare Disease Day

My daughter Juno was diagnosed with a very rare, severe neurodevelopmental condition called STXBP1-related disorder six years […]

Diagnosis

RARE Global Advocacy Alliance Member Spotlight: Geoffrey Gee

Rare Disease Caregiver Resources

National Caregiver Day in the United States falls on the third Friday of February every year, on […]

Living with a RARE Disease

Finding Me Through This Rare Journey

Patient or Advocate: Brittany Anderson Disease Affiliation: Fibrous Dysplasia, McCune Albright Syndrome, Panhypopituitarism, Adrenal Insufficiency, Trigeminal Neuralgia, […]

Diagnosis